MRSA in the United States and Beyond
MRSA in the United States and Beyond
Abstract & Commentary
By Maria D. Mileno, MD, Dr. Mileno is Associate Professor of Medicine, Warren Alpert School of Medicine, Director, Travel Medicine, The Miriam Hospital, Providence, RI.
Dr. Mileno reports no financial relationships with companies related to this field of study.
This article originally appeared in the June 2008 issue of Travel Medicine Advisor. It was edited by Frank Bia, MD, and peer reviewed by Phillip Fischer, MD, DTM&H.
Synopsis: Before 1975, infections due to methicillin-resistant Staphylococcus aureus (MRSA) were uncommon. Slowly but steadily, increased reporting of MRSA nosocomial infections occurred through the 1980s and '90s and now presents an additional risk for travelers.
Sources: Popovich KJ, et al. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis. 2008;46:787-794; Wang JL, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis. 2008;46:799-806; Boyce JM. Community-associated methicillin-resistant Staphylococcus aureus as a cause of health care-associated infection. Clin Infect Dis. 2008;46:795-798.
By 1998, community-acquired (ca) cases appeared among young children and are now widely documented, representing 15%-74% of Staphylococcus aureus skin and soft-tissue infections in US emergency departments. Still, they had not gained great attention until the St. Louis Rams made headlines in the New England Journal of Medicine.1 Two articles and an excellent editorial in the March 15th issue of Clinical Infectious Diseases describe MRSA acquired from the community and the similarities in risk factors, outcomes, and behavior of the hospital-acquired strains.
Popovich et al report a method for using molecular typing methods and antimicrobial susceptibility patterns of MRSA isolates responsible for hospital-onset bloodstream infections (BSI). They classify the isolates as either community genotypes or hospital genotypes. Over a seven-year period, the community genotype increased from 24% to 49%; this is significantly higher than the healthcare-associated infections reported at 16%-22% by other authors recently. There has been a statistically significant decrease in resistance to clindamycin, ciprofloxacin, and gentamicin among hospital-onset MRSA BSI isolates in parallel with an increase in number of BSI isolates showing community genotypes.
The article by Wang et al examined clinical features and outcomes of adults with CA-MRSA bacteremia compared to those with CA-MSSA (methicillin-sensitive S. aureus) bacteremia in Taipei, Taiwan. Thirty patients with CA-MRSA and 185 patients with CA-MSSA infections were studied. Increased numbers of patients with CA-MRSA bacteremia were documented over time. Cutaneous abscesses and necrotizing pneumonia were independent predictors of CA-MRSA bacteremia; endovascular infection was the only independent predictor of CA-MSSA bacteremia. The same mortality rates occurred in patients with CA-MRSA as with CA-MSSA. In this cohort only four of the 30 patients with CA-MRSA bacteremia received empirical agents active against MRSA within the first 48 hours of hospitalization. Shock, advanced age, and thrombocytopenia were all predictors of mortality
Commentary
In summary, clone USA 300 and similar strains of virulent MRSA have taken off like wild fire on a worldwide basis. CA strains have pulse field gel electrophoresis patterns that differ from hospital-acquired strains. Panton-Valentine Leukocidin (PVL) may provide the organisms with an ability to cause necrotizing skin and soft-tissue infections including necrotizing fasciitis, as well as necrotizing pneumonia, and with the capacity to spread rapidly. Showing slight molecular differences, similarly virulent community-acquired strains are spreading in Europe, Taiwan, and Australia. Although staphylococcal infections can occur at home or abroad, it may be important to alert travelers about the risk of MRSA clone USA 300. Travelers can be warned also that necrotizing skin infections from virulent MRSA can look like spider bites, although a study of spiders concluded that house spiders do not carry MRSA.2
References
- Kazakova SV, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:5:468-475.
- Baxtrom C, et al. Common house spiders are not likely vectors of community-acquired methicillin resistant Staphylococcus aureus infections. J Med Entomol. 2006:43:962-965.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.